pneumocandin a(0) has been researched along with Candidiasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Z; Bills, GF; Chen, L; Li, Y; Liu, X; Yue, Q | 1 |
| Abruzzo, G; Balkovec, J; Bartizal, K; Hammond, M; Krupa, D; Nollstadt, K; Schmatz, D; Schwartz, R; Trainor, C; Vanmiddlesworth, F | 1 |
| Abruzzo, GK; Fromtling, RA | 1 |
3 other study(ies) available for pneumocandin a(0) and Candidiasis
| Article | Year |
|---|---|
Genetic Manipulation of the Pneumocandin Biosynthetic Pathway for Generation of Analogues and Evaluation of Their Antifungal Activity.
Topics: Antifungal Agents; Ascomycota; Aspergillosis; Aspergillus fumigatus; Biosynthetic Pathways; Candida; Candidiasis; Echinocandins; Genetic Engineering; Humans; Multigene Family | 2015 |
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Azoles; beta-Glucans; Candida albicans; Candidiasis; Echinocandins; Glucans; Kidney; Lethal Dose 50; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrans | 1992 |
L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echinocandins; Erythrocytes; Female; Hemolysis; Kidney; Liver; Mice; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1989 |